Ras activation mediates WISP-1-induced increases in cell motility and matrix metalloproteinase expression in human osteosarcoma

Cellular Signalling

Volumn 25, Issue 12, 2013, Pages 2812-2822

  Wu, Chien Lin ^a   Tsai, Hsiao Chi ^b   Chen, Zhen Wei ^c   Wu, Chi Ming ^c   Li, Te Mao ^c   Fong, Yi Chin ^c,d   Tang, Chih Hsin ^c,e,f  

^a CHANGHUA CHRISTIAN HOSPITAL   (Taiwan)

^b NATIONAL CHUNG HSING UNIVERSITY   (Taiwan)

^c CHINA MEDICAL UNIVERSITY   (Taiwan)

^d CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^e CHINA MEDICAL UNIVERSITY   (Taiwan)

^f ASIA UNIVERSITY   (Taiwan)

Author keywords

Migration; Osteosarcoma; Raf 1; Ras; WISP 1

Indexed keywords

COLLAGENASE 3; CYSTEINE RICH PROTEIN 61; GELATINASE A; GELATINASE B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTEGRIN RECEPTOR; INTERSTITIAL COLLAGENASE; MATRIX METALLOPROTEINASE; MITOGEN ACTIVATED PROTEIN KINASE; NEUTROPHIL COLLAGENASE; PROTEIN WISP 1; RAF PROTEIN; RAS PROTEIN; STROMELYSIN; UNCLASSIFIED DRUG; VITRONECTIN RECEPTOR; CCN PROTEIN; ONCOPROTEIN; WISP1 PROTEIN, HUMAN;

ARTICLE; CANCER GRADING; CELL MIGRATION; CELL MOTILITY; CONTROLLED STUDY; ENZYME ACTIVITY; HUMAN; HUMAN CELL; HUMAN TISSUE; OSTEOSARCOMA; OSTEOSARCOMA CELL; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; TUMOR INVASION; UPREGULATION; BONE TUMOR; CELL MOTION; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PATHOLOGY; TUMOR CELL LINE;

BONE NEOPLASMS; CCN INTERCELLULAR SIGNALING PROTEINS; CELL LINE, TUMOR; CELL MOVEMENT; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INTEGRIN ALPHAVBETA3; MATRIX METALLOPROTEINASES; NF-KAPPA B; OSTEOSARCOMA; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-RAF; RAS PROTEINS; SIGNAL TRANSDUCTION;

EID: 84884800613     PISSN: 08986568     EISSN: 18733913     Source Type: Journal    
DOI: 10.1016/j.cellsig.2013.09.005     Document Type: Article

References (53)

1. Ek E.T., Choong P.F. Expert. Rev. Anticancer. Ther. 2006, 6:225-237.
2. Kempf-Bielack B., Bielack S.S., Jurgens H., Branscheid D., Berdel W.E., Exner G.U., Gobel U., Helmke K., Jundt G., Kabisch H., Kevric M., Klingebiel T., Kotz R., Maas R., Schwarz R., Semik M., Treuner J., Zoubek A., Winkler K. J. Clin. Oncol. 2005, 23:559-568.
3. Arndt C.A., Crist W.M. N. Engl. J. Med. 1999, 341:342-352.
4. Bacci G., Ferrari S., Longhi A., Perin S., Forni C., Fabbri N., Salduca N., Versari M., Smith K.V. Eur. J. Cancer 2001, 37:32-38.
5. Joyce J.A., Pollard J.W. Nat. Rev. Cancer 2009, 9:239-252.
6. Woodhouse E.C., Chuaqui R.F., Liotta L.A. Cancer 1997, 80:1529-1537.
7. Tang C.H. Biomedicine 2012, 2:92-98.
8. Egeblad M., Werb Z. Nat. Rev. Cancer 2002, 2:161-174.
9. Kerkela E., Saarialho-Kere U. Exp. Dermatol. 2003, 12:109-125.
10. Tsai Y.Y., Chiang C.C., Yeh K.T., Lee H., Cheng Y.W. Invest. Ophthalmol. Vis. Sci. 2010, 51:3462-3467.
11. Kimura R., Ishikawa C., Rokkaku T., Janknecht R., Mori N. Biochim. Biophys. Acta 2011, 1813:1543-1553.
12. Holbourn K.P., Acharya K.R., Perbal B. Trends Biochem. Sci. 2008, 33:461-473.
13. Perbal B. Mol. Pathol. 2001, 54:57-79.
14. Kleer C.G., Zhang Y., Pan Q., Merajver S.D. Neoplasia 2004, 6:179-185.
15. Kleer C.G., Zhang Y., Pan Q., van Golen K.L., Wu Z.F., Livant D., Merajver S.D. Oncogene 2002, 21:3172-3180.
16. Pennica D., Swanson T.A., Welsh J.W., Roy M.A., Lawrence D.A., Lee J., Brush J., Taneyhill L.A., Deuel B., Lew M., Watanabe C., Cohen R.L., Melhem M.F., Finley G.G., Quirke P., Goddard A.D., Hillan K.J., Gurney A.L., Botstein D., Levine A.J. Proc. Natl. Acad. Sci. U.S.A. 1998, 95:14717-14722.
17. Xu L., Corcoran R.B., Welsh J.W., Pennica D., Levine A.J. Genes Dev. 2000, 14:585-595.
18. Chen P.P., Li W.J., Wang Y., Zhao S., Li D.Y., Feng L.Y., Shi X.L., Koeffler H.P., Tong X.J., Xie D. PLoS One 2007, 2:e534.
19. Xie D., Yin D., Wang H.J., Liu G.T., Elashoff R., Black K., Koeffler H.P. Clin. Cancer Res. 2004, 10:2072-2081.
20. Campbell S.L., Khosravi-Far R., Rossman K.L., Clark G.J., Der C.J. Oncogene 1998, 17:1395-1413.
21. Marshall C.J. Curr. Opin. Cell Biol. 1996, 8:197-204.
22. Zhang X.F., Settleman J., Kyriakis J.M., Takeuchi-Suzuki E., Elledge S.J., Marshall M.S., Bruder J.T., Rapp U.R., Avruch J. Nature 1993, 364:308-313.
23. Lahsnig C., Mikula M., Petz M., Zulehner G., Schneller D., van Zijl F., Huber H., Csiszar A., Beug H., Mikulits W. Oncogene 2009, 28:638-650.
24. Lu K.W., Tsai M.L., Chen J.C., Hsu S.C., Hsia T.C., Lin M.W., Huang A.C., Chang Y.H., Ip S.W., Lu H.F., Chung J.G. Anticancer. Res. 2008, 28:1093-1099.
25. Fong Y.C., Li T.M., Wu C.M., Hsu S.F., Kao S.T., Chen R.J., Lin C.C., Liu S.C., Wu C.L., Tang C.H. J. Cell. Physiol. 2008, 217:846-855.
26. Lu D.Y., Leung Y.M., Cheung C.W., Chen Y.R., Wong K.L. Biochem. Pharmacol. 2010, 80:1201-1209.
27. Tang C.H., Chuang J.Y., Fong Y.C., Maa M.C., Way T.D., Hung C.H. Carcinogenesis 2008, 29:1483-1492.
28. Yu Y.L., Chou R.H., Liang J.H., Chang W.J., Su K.J., Tseng Y.J., Huang W.C., Wang S.C., Hung M.C. PLoS One 2013, 8:e61362.
29. Hsia T.C., Tu C.Y., Chen Y.J., Wei Y.L., Yu M.C., Hsu S.C., Tsai S.L., Chen W.S., Yeh M.H., Yen C.J., Yu Y.L., Huang T.C., Huang C.Y., Hung M.C., Huang W.C. Mol. Pharmacol. 2013, 83:857-869.
30. Cheng C.Y., Kuo C.T., Lin C.C., Hsieh H.L., Yang C.M. Br. J. Pharmacol. 2010, 160:1595-1610.
31. Hou C.H., Chiang Y.C., Fong Y.C., Tang C.H. Biochem. Pharmacol. 2011, 81:1286-1295.
32. Korpi J.T., Hagstrom J., Lehtonen N., Parkkinen J., Sorsa T., Salo T., Laitinen M. Surg. Oncol. 2011, 20:e18-e22.
33. Lin M.T., Zuon C.Y., Chang C.C., Chen S.T., Chen C.P., Lin B.R., Wang M.Y., Jeng Y.M., Chang K.J., Lee P.H., Chen W.J., Kuo M.L. Clin. Cancer Res. 2005, 11:5809-5820.
34. Tan T.W., Lai C.H., Huang C.Y., Yang W.H., Chen H.T., Hsu H.C., Fong Y.C., Tang C.H. J. Cell. Biochem. 2009, 107:345-356.
35. Brooks P.C., Stromblad S., Sanders L.C., von Schalscha T.L., Aimes R.T., Stetler-Stevenson W.G., Quigley J.P., Cheresh D.A. Cell 1996, 85:683-693.
36. Tang C.H., Tsai C.C. Biochem. Pharmacol. 2012, 83:335-344.
37. Zang M., Hayne C., Luo Z. J. Biol. Chem. 2002, 277:4395-4405.
38. Friday B.B., Adjei A.A. Clin. Cancer Res. 2008, 14:342-346.
39. Lee H.W., Ahn D.H., Crawley S.C., Li J.D., Gum J.R., Basbaum C.B., Fan N.Q., Szymkowski D.E., Han S.Y., Lee B.H., Sleisenger M.H., Kim Y.S. J. Biol. Chem. 2002, 277:32624-32631.
40. Wang S.W., Wu H.H., Liu S.C., Wang P.C., Ou W.C., Chou W.Y., Shen Y.S., Tang C.H. PLoS One 2012, 7:e35101.
41. Huang C.Y., Lee C.Y., Chen M.Y., Yang W.H., Chen Y.H., Chang C.H., Hsu H.C., Fong Y.C., Tang C.H. J. Cell. Physiol. 2009, 221:204-212.
42. Madrid L.V., Mayo M.W., Reuther J.Y., Baldwin A.S. J. Biol. Chem. 2001, 276:18934-18940.
43. Dhar, A. Ray, A. Exp. Oncol.32 2-9.
44. Tan T.W., Yang W.H., Lin Y.T., Hsu S.F., Li T.M., Kao S.T., Chen W.C., Fong Y.C., Tang C.H. Carcinogenesis 2009, 30:258-268.
45. Lin M.T., Chang C.C., Chen S.T., Chang H.L., Su J.L., Chau Y.P., Kuo M.L. J. Biol. Chem. 2004, 279:24015-24023.
46. Katsube K., Sakamoto K., Tamamura Y., Yamaguchi A. Dev. Growth Differ. 2009, 51:55-67.
47. Scherer R.L., McIntyre J.O., Matrisian L.M. Cancer Metastasis Rev. 2008, 27:679-690.
48. Reddy V.S., Valente A.J., Delafontaine P., Chandrasekar B. J. Cell. Physiol. 2011, 226:3303-3315.
49. Tanaka S., Sugimachi K., Kameyama T., Maehara S., Shirabe K., Shimada M., Wands J.R., Maehara Y. Hepatology 2003, 37:1122-1129.
50. Satoh T., Nakafuku M., Kaziro Y. J. Biol. Chem. 1992, 267:24149-24152.
51. Sheng H., Shao J., Dubois R.N. Cancer Res. 2001, 61:2670-2675.
52. Geppert T.D., Whitehurst C.E., Thompson P., Beutler B. Mol. Med. 1994, 1:93-103.
53. Xie W., Fletcher B.S., Andersen R.D., Herschman H.R. Mol. Cell. Biol. 1994, 14:6531-6539.